Soleus Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-31,136
| Closed | -$870K | – | 79 |
|
|
2021
Q1 | $870K | Hold |
31,136
| – | – | 0.16% | 68 |
|
|
2020
Q4 | $882K | Sell |
31,136
-10,481
| -25% | -$297K | 0.12% | 54 |
|
|
2020
Q3 | $1.05M | Buy |
41,617
+13,148
| +46% | +$330K | 0.55% | 41 |
|
|
2020
Q2 | $695K | Buy |
28,469
+16,600
| +140% | +$405K | 0.4% | 47 |
|
|
2020
Q1 | $176K | Sell |
11,869
-11,331
| -49% | -$168K | 0.2% | 46 |
|
|
2019
Q4 | $376K | Buy |
+23,200
| New | +$376K | 0.36% | 42 |
|